Jove
Visualize
Contact Us

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.5K
3.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.8K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

5.8K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Lncrna Fezf1-as1 Promotes The Tumorigenesis And Suppresses Ferroptosis In Non-small Cell Lung Cancer Through The Tnf-α/nf-κb Pathway.
  1. Home
  2. Lncrna Fezf1-as1 Promotes The Tumorigenesis And Suppresses Ferroptosis In Non-small Cell Lung Cancer Through The Tnf-α/nf-κb Pathway.

Related Experiment Video

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

113.6K

LncRNA FEZF1-AS1 promotes the tumorigenesis and suppresses ferroptosis in non-small cell lung cancer through the

WenRui Hou1, DianMing Li2, JingXin Wang1

  • 1Department of Respiratory and Critical Care Medicine, Bengbu Medical University, Bengbu, 233003, Anhui, China.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|October 10, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) promotes non-small cell lung cancer (NSCLC) progression by suppressing ferroptosis. Inhibiting FEZF1-AS1 activates the tumor necrosis factor-alpha (TNF-α)/nuclear factor-κB (NF-κB) axis, offering a potential therapeutic strategy.

Keywords:
FEZF1-AS1FerroptosisNF-κBNon-small cell lung cancerTNF-α

More Related Videos

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.0K

Related Experiment Videos

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

113.6K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Non-small cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
  • Ferroptosis, a regulated form of cell death, is implicated in cancer therapy.
  • The role of FEZ family zinc finger 1 antisense RNA 1 (FEZF1-AS1) in NSCLC and ferroptosis remains largely unexplored.

Purpose of the Study:

  • To investigate the impact of FEZF1-AS1 on ferroptosis in NSCLC.
  • To elucidate the molecular mechanism by which FEZF1-AS1 influences NSCLC progression.

Main Methods:

  • FEZF1-AS1 silencing was performed in NSCLC cell lines.
  • Functional assays (Cell Counting Kit-8, EdU, flow cytometry, Transwell) assessed cell proliferation, invasion, and migration.
  • Western blot analyzed proteins in the tumor necrosis factor-alpha (TNF-α)/nuclear factor-κB (NF-κB) pathway and ferroptosis markers.

Main Results:

  • FEZF1-AS1 expression was significantly upregulated in NSCLC.
  • FEZF1-AS1 silencing suppressed NSCLC cell proliferation, migration, and invasion, and enhanced ferroptosis sensitivity.
  • Knockdown of FEZF1-AS1 inhibited the TNF-α/NF-κB pathway, and TNF-α treatment reversed these effects.

Conclusions:

  • FEZF1-AS1 promotes NSCLC progression by suppressing ferroptosis.
  • The mechanism involves the activation of the TNF-α/NF-κB axis.
  • Targeting FEZF1-AS1 represents a potential therapeutic strategy for NSCLC.